Medical and Pharmaceutical
The first head-to-head clinical trial pushes the psychedelic compound closer to becoming a licensed medicine
Hi, what are you looking for?
Mugglehead Investment Magazine
Psychedelics
Canada
Vancouver activist Dana Larsen is pushing the drug-reform conversation past cannabis by opening the doors of his entheogenic coffee shop
Medical and Pharmaceutical
Early evidence shows LSD promotes social behaviour in rodents, but pharmaceutical research is still a ways off
Medical and Pharmaceutical
A recent review suggests natural settings and activities can complement all stages of psychedelic-assisted therapy
Analysis
With solid efficacy and low cost, the popular club drug could help curb the personal toll and multi-billion dollar cost of North America's battle...
Canada
Proposed by Health Canada, the change would allow patients to access restricted substances like MDMA through the Special Access Program
Psychedelics
With major research, legal reform, and more than 20 firms going public, it was major year for the re-emerging field
Analysis
Following a surge of interest, ibogaine therapy in the country disappeared. But recent signs show regulators are warming to the promising plant
Health and Safety
After a successful ballot measure, a broad set of onlookers focuses on Oregon to gauge the social and economic impacts of licensed psilocybin therapy
Investment Ideas
Through its university partnership, the firm wants to attract big pharma backers by making 100,000s of novel psychedelic derivatives for new precision medicine
